Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Prepaid Assets: 2014-2024

Historic Prepaid Assets for Zevra Therapeutics (ZVRA) over the last 9 years, with Dec 2024 value amounting to $4.1 million.

  • Zevra Therapeutics' Prepaid Assets rose 225.04% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 225.04%. This contributed to the annual value of $4.1 million for FY2024, which is 122.15% up from last year.
  • According to the latest figures from FY2024, Zevra Therapeutics' Prepaid Assets is $4.1 million, which was up 122.15% from $1.8 million recorded in FY2023.
  • In the past 5 years, Zevra Therapeutics' Prepaid Assets registered a high of $4.1 million during FY2024, and its lowest value of $1.2 million during FY2021.
  • Over the past 3 years, Zevra Therapeutics' median Prepaid Assets value was $1.8 million (recorded in 2023), while the average stood at $2.5 million.
  • As far as peak fluctuations go, Zevra Therapeutics' Prepaid Assets fell by 20.19% in 2021, and later soared by 122.15% in 2024.
  • Yearly analysis of 5 years shows Zevra Therapeutics' Prepaid Assets stood at $1.5 million in 2020, then declined by 20.19% to $1.2 million in 2021, then skyrocketed by 42.81% to $1.7 million in 2022, then rose by 8.06% to $1.8 million in 2023, then skyrocketed by 122.15% to $4.1 million in 2024.